What does my Breast Cancer pathology report mean
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Your Breast Cancer Pathology Report
I'd be happy to help you understand your pathology report! However, I don't see that you've uploaded or shared your specific report yet.
To give you the most helpful explanation, please share:
- A photo, scan, or text of your pathology report, OR
- The key findings from your report (even if you just type out the main results)
What I Can Help You Understand
Once you share your report, I can explain:
✅ Tumor characteristics - What type of breast cancer you have (ductal, lobular, etc.)
✅ Biomarker results - Your hormone receptor (ER/PR) and HER2 status, which are critical for treatment planning
✅ Grade and stage information - What these numbers mean for your cancer's behavior
✅ Specific findings - Any mutations or other test results mentioned
✅ What's typical - How your results compare to standard reference ranges
Key Pathology Information (General Context)
According to NCCN Guidelines for Invasive Breast Cancer, your pathology report will typically include testing for:
- Estrogen Receptor (ER) status - Does your cancer respond to estrogen?
- Progesterone Receptor (PR) status - Does your cancer respond to progesterone?
- HER2 status - Does your cancer have too much of a specific growth protein?
- Grade - How quickly the cancer cells are growing
- Histology - The specific type of breast cancer cells
These results directly guide which treatments your oncologist will recommend.
Please upload or share your pathology report, and I'll walk you through what it means in plain language.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Breast Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Im interested in integrative options to pysh cancer back in remission. No need tO Rely of NCCN, use data from...
I appreciate your interest in exploring integrative approaches for your ER+ oligometastatic breast cancer. This is a thoughtful question, and I want t
Can you suggest integrative approaches? Possibly i can stop the progression. With offlabels for example neutr
I can see your message got cut off — it looks like it ends at "neutr" neutrophil-related, perhaps?. Before I give you a comprehensive answer about in
What lifestyle changes are recommended for Breast Cancer patients
Given your ER-positive oligometastatic breast cancer and your current treatment with ribociclib, lifestyle modifications play an important supporting
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I want to make sure I'm giving you the most helpful educational information. Let me clarify what I'm seeing in your message — it looks like it got cut
How do I find the best clinical trial for breast cancer
Clinical trials can be an important option to explore as part of your breast cancer treatment plan. Here's how to approach finding one that might be r